Kyntra Bio KYNB
NASDAQ KYNB
$5.21 -0.14 (-2.70%)
At close: Oct 21, 2026 · 4:00 PM EDT

Kyntra Bio (KYNB) Research & Development (2014 - 2026)

Updated

Kyntra Bio's Research & Development came in at $6.82 million for Q2 2026, up 16.3% from $5.87 million a year earlier but down 9.8% from the prior quarter.

Analysis

Kyntra Bio (KYNB) Research & Development (2014 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Kyntra Bio reported Research & Development of $22.86 million, down 45.4% year-over-year; for FY2025, it came in at $23.52 million, down 75.4% from FY2024.

  • Research & Development has declined in each of the last four years, with a five-year compound annual growth rate of -37.8% (FY2020 to FY2025).
  • Going back by year, Research & Development was $95.69 million in FY2024 (-64.1%), $266.47 million in FY2023 (-10.2%), $296.79 million in FY2022 (-23.3%) and $387.04 million in FY2021 (+53.0%).
  • The five-year range for quarterly Research & Development is $1.21 million (Q3 2025) to $113.92 million (Q4 2021).
  • Year-over-year, Research & Development increased in two of the last eight quarters, with an average decline of 49.3%.
  • The fastest year-over-year change in Research & Development over five years came in Q4 2021 (growth of 45.8%), and the weakest in Q3 2025 (a decline of 93.9%).
  • Business Quant data shows KYNB's Research & Development at $7.57 million (Q1 2026), $7.27 million (Q4 2025) and $1.21 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 3.65 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.34 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 4.05 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 1.76 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 2.81 Bn
10 Kyntra Bio 21.25 Mn -386.69 Mn 1.47 Mn 6.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.82 Mn
Mar 31, 2026 7.57 Mn
Dec 31, 2025 7.27 Mn
Sep 30, 2025 1.21 Mn
Jun 30, 2025 5.87 Mn
Mar 31, 2025 9.18 Mn
Dec 31, 2024 6.87 Mn
Sep 30, 2024 19.97 Mn
Jun 30, 2024 32.36 Mn
Mar 31, 2024 36.49 Mn
Dec 31, 2023 35.32 Mn
Sep 30, 2023 61.19 Mn
Jun 30, 2023 95.48 Mn
Mar 31, 2023 74.49 Mn
Dec 31, 2022 61.63 Mn
Sep 30, 2022 75.18 Mn
Jun 30, 2022 70.96 Mn
Mar 31, 2022 89.02 Mn
Dec 31, 2021 113.92 Mn
Sep 30, 2021 75.88 Mn
API Access

Kyntra Bio Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=KYNB&period=max&api_key=YOUR_API_KEY